Fischer Medical Ventures Latest Share Price (FISCHER)
TODAY IN ONE LINE
FISCHER rose 1.3% on light volume, in line with Nifty's 0.5% move, supported by recent strong earnings.
With a market cap of ₹2,597.71 Cr., it trades at a P/E of 79.28. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Fischer Medical Ventures flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 62.1% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.28x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 8.6%
- ●Expensive ValuationTrading at a high P/E ratio of 86.8x
Latest Fischer Medical Ventures News
What changed recently?
Recent events, corporate actions, and announcements.
Fischer Medical Ventures Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Fischer Medical Ventures Limited, framed against the sector median so the premium or discount is obvious at a glance.
Fischer Medical Ventures Limited trades at a P/E of 79.28× and P/B of 6.21×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Fischer Medical Ventures Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Fischer Medical Ventures Limited — derived from the latest tape, not yesterday's close.
Fischer Medical Ventures Limited last traded at ₹36.93 with an intraday range of ₹36.1–₹37.4 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹36.93| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 40.12 | +3.19 | +8.64% |
| R3 | 38.82 | +1.89 | +5.12% |
| R2 | 38.11 | +1.18 | +3.20% |
| R1 | 37.52 | +0.59 | +1.60% |
| PIVOT | 36.81 | -0.12 | -0.32% |
| CURRENT | 36.93 | — | — |
| S1 | 36.22 | -0.71 | -1.92% |
| S2 | 35.51 | -1.42 | -3.85% |
| S3 | 34.92 | -2.01 | -5.44% |
| S4 | 33.62 | -3.31 | -8.96% |
FISCHER is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹36.1–₹37.39
Trading Inside opening range
Fischer Medical Ventures Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Fischer Medical Ventures Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Fischer Medical Ventures Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,597.71 Cr. and reported EPS of ₹0.43.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 111 | 309 ▲ 178.8% |
| Sales Growth YoY %Derived | 427.61% | 178.75% |
| Other Income | 1 | 12 ▲ 725.3% |
| Total Income | 112 | 321 ▲ 186.0% |
| 92 | 143 ▲ 55.7% | |
| Gross ProfitDerived | 19 | 166 ▲ 768.7% |
| Gross Margin %Derived | 17.26% | 53.79% |
| 16 | 123 ▲ 678.3% | |
| EBITDA (Operating Profit)Derived | 3 | 43 ▲ 1198.9% |
| OPM %Derived | 3.00% | 13.96% |
| 2 | 9 ▲ 446.4% | |
| Profit Before Tax (PBT) | 2 | 47 ▲ 1995.8% |
| 1 | 15 ▲ 1411.9% | |
| Effective Tax %Derived | 45.66% | 32.94% |
| Total Profit for Period | 1 | 31 ▲ 2468.0% |
| Less: Non-controlling Interests | -0 | — ▲ 100.0% |
| Net Profit (Owner's PAT)Derived | 1 | 31 ▲ 1993.6% |
| Net Profit Margin %Derived | 1.34% | 10.05% |
| PAT Growth YoY %Derived | -19.39% | 1,993.64% |
| Earnings Per Share (EPS ₹) | 0.02 | 0.47 ▲ 2250.0% |
| Diluted Shares Outstanding (Cr) | 64 | 65 ▲ 2.6% |
| Share of Profit from Associates/JVs | — | -0 |
| Other Comprehensive Income (Net of Tax) | -0 | 0 ▲ 796.2% |
| Total Expenses (incl. D&A & Interest) | 110 | 274 ▲ 149.4% |
| Material Cost % of RevenueDerived | — | 20.17% |
| Employee Cost % of RevenueDerived | 2.33% | 4.89% |
| Other Cost % of RevenueDerived | 11.93% | 34.94% |
| Interest Coverage (x)Derived | 3.61x | 6.87x |
| Period | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|
| Revenue from Operations | 21 | 111 ▲ 427.6% | 309 ▲ 178.8% | |
| Sales Growth YoY %Derived | — | 427.61% | 178.75% | |
| Other Income | 1 | 1 ▲ 197.7% | 12 ▲ 725.3% | |
| Total Income | 21 | 112 ▲ 422.2% | 321 ▲ 186.0% | |
16 | 92 ▲ 456.6% | 143 ▲ 55.7% | ||
| Gross ProfitDerived | 5 | 19 ▲ 322.1% | 166 ▲ 768.7% | |
| Gross Margin %Derived | 21.58% | 17.26% | 53.79% | |
3 | 16 ▲ 492.0% | 123 ▲ 678.3% | ||
| EBITDA (Operating Profit)Derived | 2 | 3 ▲ 78.4% | 43 ▲ 1198.9% | |
| OPM %Derived | 8.86% | 3.00% | 13.96% | |
0 | 2 ▲ 546.0% | 9 ▲ 446.4% | ||
| Profit Before Tax (PBT) | 2 | 2 ▲ 5.3% | 47 ▲ 1995.8% | |
0 | 1 ▲ 271.3% | 15 ▲ 1411.9% | ||
| Effective Tax %Derived | 12.95% | 45.66% | 32.94% | |
| Total Profit for Period | 2 | 1 ▼ 34.3% | 31 ▲ 2468.0% | |
| Less: Non-controlling Interests | — | -0 | — ▲ 100.0% | |
| Net Profit (Owner's PAT)Derived | 2 | 1 ▼ 19.4% | 31 ▲ 1993.6% | |
| Net Profit Margin %Derived | 8.76% | 1.34% | 10.05% | |
| PAT Growth YoY %Derived | — | -19.39% | 1,993.64% | |
| Earnings Per Share (EPS ₹) | 0.03 | 0.02 ▼ 33.3% | 0.47 ▲ 2250.0% | |
| Diluted Shares Outstanding (Cr) | 54 | 64 ▲ 19.3% | 65 ▲ 2.6% | |
| Share of Profit from Associates/JVs | — | — | -0 | |
| Other Comprehensive Income (Net of Tax) | — | -0 | 0 ▲ 796.2% | |
| Total Expenses (incl. D&A & Interest) | 19 | 110 ▲ 467.7% | 274 ▲ 149.4% | |
| Material Cost % of RevenueDerived | 75.01% | — | 20.17% | |
| Employee Cost % of RevenueDerived | 1.82% | 2.33% | 4.89% | |
| Other Cost % of RevenueDerived | 10.90% | 11.93% | 34.94% | |
| Interest Coverage (x)Derived | 24.82x | 3.61x | 6.87x |
Fischer Medical Ventures segment analysis : revenue and profit mix.
Disclosed business segments at Fischer Medical Ventures with their share of revenue and profit, switchable between consolidated and standalone reporting.
Fischer Medical Ventures discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Fischer Medical Ventures Limited.
Our AI distills the core fundamental drivers supporting Fischer Medical Ventures Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Fischer Medical Ventures Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
TTM revenue growth 98.7% YoY far exceeds typical peer growth rates significantly.
Promoter holding 62.15% rising to 74.91% reflects strong management commitment and alignment.
Low debt-to-equity ratio 0.0028x provides substantial financial flexibility for growth.
Operating margin 14.00% quarterly demonstrates reasonable operational efficiency and control.
Quarterly sales surged to ₹86.3 Cr, demonstrating robust expansion momentum recently.
Key Risks.
P/E ratio 86.81x signals severe overvaluation versus peer median 43–48x substantially.
Operating cash flow negative ₹694.9 Cr latest quarter, indicating weak earnings quality.
ROE 8.59% and ROCE 11.40% lag industry averages substantially and persistently.
Dividend yield 0.01% offers minimal shareholder income or capital returns whatsoever.
EV/EBITDA 379.13x far exceeds peer median 25–26x, unsustainable valuation entirely.
Flip Conditions.
Valuation risk. a P/E above 103 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Fischer Medical Ventures Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Fischer Medical Ventures Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Fischer Medical Ventures Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Fischer Medical Ventures Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Fischer Medical Ventures Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Fischer Medical Ventures Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Fischer Medical Ventures Limited stood at 58.3% of traded volume, against a 20-day average of 44.1%.
Fischer Medical Ventures announcements: results, concalls, ratings, M&A.
Filings Fischer Medical Ventures sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Fischer Medical Ventures files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 99 documents below.
General Updates
Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants
Resignation of Director/KMP/SMP
Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP
Resignation of Director/KMP/SMP
Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP
General Updates
Fischer Medical Ventures Limited has informed the Exchange on allotment of Equity shares pursuant to conversion of warrants
Change in Director(s)
Fischer Medical Ventures Limited has informed the Exchange regarding Change in Director(s) of the company.
Fischer Medical Ventures dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Fischer Medical Ventures has declared, sequenced by announce and record date.
Fischer Medical Ventures corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Fischer Medical Ventures insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Fischer Medical Ventures as reported to SEBI — buying and selling signals from the people who know the business best.
Fischer Medical Ventures insider activity below tracks 6 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr. | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr. | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr. | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr. | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr. | ₹23.40 |
| SHANKAR VARADHARAJAN | Insider | 31 Mar 2026 | buy | +60.00 L | ₹14.04 Cr. | ₹23.40 |
About Fischer Medical Ventures Limited: business, sector, key facts.
What Fischer Medical Ventures Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Fischer Medical Ventures Limited operates in the Medical Equipment & Supplies industry under the Healthcare sector, listed as NSE: FISCHER, BSE: 524743.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Fischer Medical Ventures Limited (FISCHER).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Fischer Medical Ventures Limited (FISCHER)?
The current share price of Fischer Medical Ventures Limited (FISCHER) is ₹36.93. Today, the stock has gained by ₹0.46 (1.26%), trading in a range of ₹36.10 to ₹37.40. The stock opened at ₹36.10 with a trading volume of 5,67,350 shares.
02Is Fischer Medical Ventures Limited stock a good investment for long-term?
Fischer Medical Ventures Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,597.71 Cr., P/E ratio of 79.28, ROE of 8.59%, and ROCE of 11.4%. The dividend yield stands at 0.01%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Fischer Medical Ventures Limited stock?
The 52-week high price of Fischer Medical Ventures Limited (FISCHER) is ₹1,194.40, while the 52-week low is ₹31.05. Currently trading at ₹36.93, the stock is 18.94% above its 52-week low and 96.91% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Fischer Medical Ventures Limited stock at the current price?
Whether to buy Fischer Medical Ventures Limited stock at ₹36.93 depends on multiple factors. The stock is currently trading with a P/E ratio of 79.28 and P/B ratio of 6.21. Today's performance shows a gain of 1.26%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Fischer Medical Ventures Limited and when is the next dividend?
Fischer Medical Ventures Limited offers a dividend yield of 0.01%, which means for every ₹100 invested at the current price of ₹36.93, you can expect to receive approximately ₹0.01 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Fischer Medical Ventures Limited?
Fischer Medical Ventures Limited's key financial metrics include: P/E Ratio: 79.28, P/B Ratio: 6.21, ROE: 8.59%, ROCE: 11.4%, Dividend Yield: 0.01%, EPS: ₹0.43, Book Value: ₹5.96, and Debt-to-Equity: 0.28. The company's market cap stands at ₹2,597.71 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Fischer Medical Ventures Limited stock performing today in the market?
Fischer Medical Ventures Limited stock opened at ₹36.10 and is currently trading at ₹36.93, showing a gain of ₹0.46 (1.26%). The intraday high is ₹37.40 and low is ₹36.10. The trading volume stands at 5,67,350 shares, indicating moderate market participation today.
08What is the P/E ratio of Fischer Medical Ventures Limited and what does it indicate?
Fischer Medical Ventures Limited has a Price-to-Earnings (P/E) ratio of 79.28, which means investors are willing to pay 79.28 for every ₹1 of earnings. With an EPS of ₹0.43, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Fischer Medical Ventures Limited (FISCHER) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.